News und Analysen

Regulatory News:

NANOBIOTIX (Paris:NANO)(Euronext: NANO - ISIN: FR0011341205 – the “Company”), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today

PRESS RELEASE

NUMBER OF SHARES AND VOTING RIGHTS COMPRISING

ANTALIS SHARE CAPITAL AS AT 25 MAY 2020

The total number of voting rights and shares comprising Antalis share capital as of the publication date of the

Paragon ID (Euronext Paris - FR0011980077 - PID), the leading provider of identification solutions for e-ID, Transport & Smart Cities, Traceability & Brand Protection, and Payment, has partnered

Verimatrix, (Euronext Paris: VMX), führender Anbieter von kundenfreundlichen Sicherheitslösungen für die moderne vernetzte Welt, meldete heute einen Spitzenplatz in der Video Content Security

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it has ranked at the top of Omdia’s Video Content Security

Regulatory News:

The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 27, 2020) at 10:00 a.m. at the Company's headquarters (400

• Editorial by Thomas Georgeon and Bruno Meyer
• Dividend payment of € 2 per share
• Mr. Didier Ridoret, appointed new Chairman of the Board of Directors
• Change in the composition of the Board and

Verimatrix, (Euronext Paris: VMX), führender Anbieter von kundenfreundlichen Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass seine VCAS™ 5 for DVB-Lösung einer der

• Growth held back by the impact of the Covid-19 crisis in the 4^th quarter
• 2019/20: current EBITDA¹ expected in line with market forecasts, free cash-flow under control
• A comfortable cash position

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that its VCAS™ 5 for DVB solution is a winner of the 2020 Future

• Activity still impacted in Q2 by the COVID crisis, subject to variation according to geographies
• Q2 expected sales circa €60m, firmly up on Q1 but down vs. Q2 2019
• New client wins showing

Saturday, 23 May 2020

Olympique Lyonnais acknowledges that the Paris Administrative Court has declared itself incompetent with regard to form, concerning OL's appeal against the 30 April 2020

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling

Press release

Boulogne-Billancourt, 20 May 2020

Resilient operating performances in 2019 in very tough market conditions,

aggravated by Antalis' specific circumstances regarding its ownership

Press Release

Boulogne-Billancourt, 20 May 2020

Exercise of the put option by Sequana and signature of a sale and purchase agreement by Kokusai Pulp & Paper Co., Ltd. for all Antalis shares held by

Thanks for reading: These shares have been exchanged for shares of LDLC ASVEL, pursuant to the agreements signed on 21 June 2019; they represent an additional investment of 1,67% in the share

Lyon, 19 May 2020

Olympique Lyonnais Groupe has reallocated 72,949 shares held in treasury, representing a portion of the shares acquired under the Company's share buyback programme.

These shares

Paris, 19 May 2020 – Net Asset Value per share was €24.21 as of 31 March 2020, down 12.7% from 31 December 2019. NAV has thus returned to near its level of 30 June 2019 (€24.54/share), the Covid-19

2020 Q1 REVENUE: €195.8 MILLION

BUSINESS AND ORDER INTAKE REMAIN RESILIENT DESPITE A TURBULENT ENVIRONMENT

ABEO, a world leader in sports and leisure equipment, today announces its revenue and order intake for the financial year ended 31 March 2020.

Regulatory News:

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”)

Regulatory News:

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a

Regulatory News:

ESI Group, Paris, France, (ISIN Code: FR0004110310, Symbol: ESI) (Paris:ESI), announces the availability of its Universal Registration Document, filed with the Autorité des

In accordance with article L233-8 of commercial law, Wavestone informs its shareholders that as of April 30, 2020, its capital was composed of 20,196,492 shares representing 23,988,683 voting rights